HMC launches Physical Medicine and Rehabilitation Residency Programme
Tribune News Network
Doha
Hamad Medical Corporation's (HMC) Qatar Rehabilitation Institute (QRI) has announced the official launch of a four-year Physical Medicine and Rehabilitation (PM&R) Residency Programme, a milestone initiative that marks a major leap forward in advancing Qatar's academic medicine and rehabilitation workforce development.
The programme will commence in the upcoming academic year and is developed in alignment with international standards. This programme positions QRI as a regional leader in training future physiatrists with unparalleled access to cutting-edge technologies, interdisciplinary care, and structured academic mentorship.
Dr Hanadi Al Hamad, deputy chief of Rehabilitation, Long-Term Care, and Geriatrics, and CEO and medical director of Qatar Rehabilitation Institute, expressed her pride: 'This is a prestigious achievement for QRI and for Qatar. Establishing the PM&R Residency Programme reflects our firm commitment to capacity building, clinical excellence, and innovation in rehabilitation. It is a key milestone in our strategy development as well as Qatar's National Health Strategy 2024-2030. Enhanced by the WHO's Rehabilitation 2030 initiative, we are not only shaping careers, we are shaping the future of rehabilitation in Qatar.'
Dr Abdulla Rashid Al Naimi, deputy chief medical officer, Medical Education at HMC, emphasised the broader strategic value: 'The launch of this residency programme exemplifies how HMC is driving Qatar's transformation into a knowledge-based, healthcare-leading nation. It supports our vision of building a sustainable, highly skilled medical workforce and is a platform for empowerment, excellence, and future leadership.'
The PM&R Residency Programme is the first of its kind in Qatar, offering a structured, accredited curriculum that empowers residents to grow into independent, research-driven, and globally competent specialists. Residents will gain hands-on experience in advanced rehabilitation services, including neuromodulation, GAIT analysis, virtual reality therapy, and spasticity management, all within a world-class, multidisciplinary clinical environment.
Dr Fatma Jassim Al-Kuwari, acting chairperson of Physical Medicine & Rehabilitation and the driving force behind the establishment of the programme, commented: 'This programme is a turning point for Qatari medical graduates. It creates a direct and prestigious pathway to specialise in physical medicine and rehabilitation within our own health system. By investing in our future physicians, we are building a self-sufficient and resilient rehabilitation ecosystem that supports national priorities and inspires our youth to pursue excellence in this vital specialty.'
This milestone also reflects Qatar's commitment to fostering innovation, research, and clinical leadership within rehabilitation medicine. By investing in advanced medical education, HMC and QRI are paving the way for long-term improvements in patient care, service delivery, and professional development across the continuum of care.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Tribune
4 days ago
- Qatar Tribune
HMC launches Physical Medicine and Rehabilitation Residency Programme
Tribune News Network Doha Hamad Medical Corporation's (HMC) Qatar Rehabilitation Institute (QRI) has announced the official launch of a four-year Physical Medicine and Rehabilitation (PM&R) Residency Programme, a milestone initiative that marks a major leap forward in advancing Qatar's academic medicine and rehabilitation workforce development. The programme will commence in the upcoming academic year and is developed in alignment with international standards. This programme positions QRI as a regional leader in training future physiatrists with unparalleled access to cutting-edge technologies, interdisciplinary care, and structured academic mentorship. Dr Hanadi Al Hamad, deputy chief of Rehabilitation, Long-Term Care, and Geriatrics, and CEO and medical director of Qatar Rehabilitation Institute, expressed her pride: 'This is a prestigious achievement for QRI and for Qatar. Establishing the PM&R Residency Programme reflects our firm commitment to capacity building, clinical excellence, and innovation in rehabilitation. It is a key milestone in our strategy development as well as Qatar's National Health Strategy 2024-2030. Enhanced by the WHO's Rehabilitation 2030 initiative, we are not only shaping careers, we are shaping the future of rehabilitation in Qatar.' Dr Abdulla Rashid Al Naimi, deputy chief medical officer, Medical Education at HMC, emphasised the broader strategic value: 'The launch of this residency programme exemplifies how HMC is driving Qatar's transformation into a knowledge-based, healthcare-leading nation. It supports our vision of building a sustainable, highly skilled medical workforce and is a platform for empowerment, excellence, and future leadership.' The PM&R Residency Programme is the first of its kind in Qatar, offering a structured, accredited curriculum that empowers residents to grow into independent, research-driven, and globally competent specialists. Residents will gain hands-on experience in advanced rehabilitation services, including neuromodulation, GAIT analysis, virtual reality therapy, and spasticity management, all within a world-class, multidisciplinary clinical environment. Dr Fatma Jassim Al-Kuwari, acting chairperson of Physical Medicine & Rehabilitation and the driving force behind the establishment of the programme, commented: 'This programme is a turning point for Qatari medical graduates. It creates a direct and prestigious pathway to specialise in physical medicine and rehabilitation within our own health system. By investing in our future physicians, we are building a self-sufficient and resilient rehabilitation ecosystem that supports national priorities and inspires our youth to pursue excellence in this vital specialty.' This milestone also reflects Qatar's commitment to fostering innovation, research, and clinical leadership within rehabilitation medicine. By investing in advanced medical education, HMC and QRI are paving the way for long-term improvements in patient care, service delivery, and professional development across the continuum of care.
Qatar Tribune
6 days ago
- Qatar Tribune
WHO honours HMC's Tobacco Control Center with 2025 World No Tobacco Day Award
DOHA: The World Health Organization (WHO) has recognized Hamad Medical Corporation's (HMC) Tobacco Control Center with the 2025 World No Tobacco Day Award. The award recognizes the Center's significant efforts in reducing tobacco use and helping the public in Qatar and the Eastern Mediterranean region to quit all forms of tobacco use. HMC's Tobacco Control Center, which has been a WHO Collaborating Center since 2017, was selected as one of the award recipients in the Eastern Mediterranean region. This marks the second time the Center has received the award, having first been honored in 2021. The award was presented by WHO Representative in Qatar Dr Rayana Bou Haka, in the presence of HMC's Deputy Chief Medical Officer for Medical Services and Chairman of the Department of Medicine Dr. Ahmed Al Mohammed. Director of HMC's Tobacco Control Center Dr Ahmad Mohamed Al Mulla, expressed his pride in the Center receiving the award for the second time. He praised the dedication of the Center's team and the achievements in tobacco control in Qatar and the Eastern Mediterranean region. He said: "This recognition by WHO reflects the positive outcomes of the hard work carried out by the Center's team and its impact on many tobacco users in our community." In turn Dr Rayana Bou Haka also commended the Center's local and regional activities and said the award was well-deserved. She thanked the Center's staff for their continued efforts in tobacco control in Qatar and the region and emphasized the importance of continued collaboration between the Center and WHO, given the significant value of its tobacco control programs. The Tobacco Control Center organizes educational and awareness initiatives targeting school and university students, as well as employees in ministries and public institutions. The Center also delivers training programs for healthcare professionals and community organizations in Qatar and across the Eastern Mediterranean. In addition, it provides smoking cessation services and conducts research in the field of tobacco cessation. WHO annually recognizes individuals and institutions from each of its six regions on the occasion of World No Tobacco Day for their outstanding contributions to tobacco control. The recognition includes honorary awards, special certificates of appreciation from the WHO Director-General, and awards specifically related to World No Tobacco Day.
Qatar Tribune
6 days ago
- Qatar Tribune
WHO honours HMC's Tobacco Control Centre with 2025 World No Tobacco Day Award
Tribune News Network Doha The World Health Organization (WHO) has recognised Hamad Medical Corporation's (HMC) Tobacco Control Centre with the 2025 World No Tobacco Day Award. The award recognises the Centre's significant efforts in reducing tobacco use and helping the public in Qatar and the Eastern Mediterranean region to quit all forms of tobacco use. HMC's Tobacco Control Centre, which has been a WHO Collaborating Centre since 2017, was selected as one of the award recipients in the Eastern Mediterranean region. This marks the second time the Centre has received the award, having first been honoured in 2021. The award was presented by Dr. Rayana Bou Haka, WHO representative in Qatar, in the presence of Dr. Ahmed Al Mohammed, HMC's deputy chief medical officer for medical services and chairman of the Department of Medicine. Dr Ahmad Mohamed Al Mulla, director of HMC's Tobacco Control Centre, expressed his pride in the Centre receiving the award for the second time. He praised the dedication of the Centre's team and the achievements in tobacco control in Qatar and the Eastern Mediterranean region. He said: 'HMC's Tobacco Control Centre has played a pioneering role in helping members of the public quit all forms of tobacco. This recognition by WHO reflects the positive outcomes of the hard work carried out by the Centre's team and its impact on many tobacco users in our community.' Dr. Rayana Bou Haka also commended the Centre's local and regional activities and said the award was well-deserved. She thanked the Centre's staff for their continued efforts in tobacco control in Qatar and the region and emphasised the importance of continued collaboration between the Centre and WHO, given the significant value of its tobacco control programs. The Tobacco Control Centre organizes educational and awareness initiatives targeting school and university students, as well as employees in ministries and public institutions. The Centre also delivers training programs for healthcare professionals and community organizations in Qatar and across the Eastern Mediterranean. In addition, it provides smoking cessation services and conducts research in the field of tobacco cessation. Dr Ahmad Al Mulla extended his gratitude to HMC leadership and the WHO Eastern Mediterranean Regional Office, represented by Dr Fatimah El Awa, WHO's Regional Advisor for the Tobacco Free Initiative, as well as the WHO Tobacco Free Initiative Office in Geneva, for their continuous support of the Centre's programs. He noted that this support contributes to the positive impact of the Centre's tobacco control activities at all levels in Qatar and the wider region. WHO annually recognizes individuals and institutions from each of its six regions on the occasion of World No Tobacco Day for their outstanding contributions to tobacco control. The recognition includes honorary awards, special certificates of appreciation from the WHO Director-General, and awards specifically related to World No Tobacco Day.
